Jane Street’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$87.4K Buy
48,300
+27,300
+130% +$47.2K ﹤0.01% 10712
2025
Q4
$28.4K Sell
21,000
-4,700
-18% -$6.69K ﹤0.01% 10657
2025
Q3
$41.9K Buy
+25,700
New +$28.5K ﹤0.01% 10392
2024
Q2
Sell
-13,800
Closed -$22.6K 9952
2024
Q1
$22.6K Buy
+13,800
New +$11.6K ﹤0.01% 8881
2023
Q1
Sell
-21,900
Closed -$28.5K 9661
2022
Q4
$28.5K Sell
21,900
-74,500
-77% -$116K ﹤0.01% 8516
2022
Q3
$172K Sell
96,400
-43,500
-31% -$108K ﹤0.01% 8304
2022
Q2
$318K Sell
139,900
-189,500
-58% -$453K ﹤0.01% 7514
2022
Q1
$1.09M Buy
329,400
+16,800
+5% +$59K ﹤0.01% 5962
2021
Q4
$1.42M Buy
312,600
+59,000
+23% +$446K ﹤0.01% 5203
2021
Q3
$1.82M Sell
253,600
-1,054,500
-81% -$7.74M ﹤0.01% 4665
2021
Q2
$10.5M Buy
1,308,100
+894,100
+216% +$7.55M ﹤0.01% 1650
2021
Q1
$2.81M Buy
+414,000
New +$2.75M ﹤0.01% 3383

Other funds holding OCGN

Jane Street's OCGN Position: Q1 2026 in Review

Jane Street increased its Ocugen (OCGN) stake by 117% in Q1 2026, buying an estimated $3.44M and bringing the position to 3,678,655 shares worth $6.66M. The position accounts for ﹤0.01% of the portfolio, ranked #3096.

Jane Street first reported a position in OCGN in Q3 2018 and has held it in 23 quarters since. The position peaked at $7.95M in Q2 2021. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • Jane Street held 3,678,655 shares of Ocugen worth $6.66M as of Q1 2026.
  • Jane Street bought 1,986,521 Ocugen shares in Q1 2026, an estimated $3.44M.
  • Ocugen made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3096 holding.
  • Jane Street first reported a position in Ocugen in Q3 2018 and has held it in 23 quarters since.
  • Jane Street's Ocugen position peaked at $7.95M in Q2 2021.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.